Course participant reviews for Regulatory Affairs For Clinical Trials
Average rating 4.6
The CTA overview and resources provided were very good. The majority of the content was relevant to the intersection of CT's and Regulations, which is what my work focus is.
The case studies and interactive nature of the course was the aspects I enjoyed the most. I also liked the introduction session.
The trainer had a good amount of knowledge and I found the slides used were great. Overall, the course met my needs.
In found the course very informative and interactive. It was a great overview of regulatory affairs.
I took this course to gain a holistic overview of requirements for conducting clinical trials in the EU. I enjoyed the description of the new process for submission/evaluation o...
“Great exercises; good descriptions about problems with the CT directive and the background for the new CT Regulation” - Global Regulatory Affairs Associate – Ferring Pharmaceut...
“10/10 – Very informative. Laura is both very knowledgeable, interactive and engaging. Found course excellent coverage. Laura agreed to answer some follow up questions if requir...
I felt the course was very complete. The interaction with the trainer was great and it was good to have an overview on regulatory affairs for clinical trials.